Condition | TOHVHP HCV group | General population | HCV:General popn | ||
---|---|---|---|---|---|
N = 1209 | N = 6045 | Prevalence ratio (95% CI) | |||
n | Prevalence (%) | n | Prevalence (%) | Â | |
Acute myocardial infarctiona | < 6 | – | < 17 | – | – |
Asthma | 206 | 19.40 | 746 | 14.74 | 1.32 (1.06–1.64) |
Cancer (any)* | 83 | 7.78 | 241 | 4.42 | 1.76 (1.22–2.55) |
Cardiac arrhythmia | 31 | 2.60 | 258 | 4.19 | 0.62 (0.37–1.06) |
Chronic obstructive pulmonary disease* | 97 | 7.78 | 137 | 3.22 | 2.42 (1.73–3.39) |
Congestive heart failure* | 46 | 3.79 | 122 | 3.14 | 1.21 (0.77–1.88) |
Chronic coronary syndrome | 89 | 5.61 | 422 | 5.79 | 0.97 (0.68–1.38) |
Dementiaa | < 13 | – | 48 | – | – |
Diabetes | 207 | 13.27 | 819 | 10.07 | 1.32 (1.06–1.64) |
Hypertension | 364 | 24.97 | 1746 | 23.14 | 1.08 (0.91–1.27) |
Non psychotic mood and anxiety disorders | 330 | 31.24 | 805 | 14.08 | 2.22 (1.86–2.64) |
Other mental illness | 157 | 13.35 | 308 | 4.93 | 2.71 (2.06–3.55) |
Osteoporosis | 35 | 3.11 | 157 | 3.35 | 0.93 (0.55–1.58) |
Rheumatoid arthritis | 22 | 1.19 | 55 | 0.97 | 1.23 (0.67–2.24) |
Renal failure* | 87 | 6.19 | 97 | 2.12 | 2.92 (1.90–4.48) |
Stroke* | 22 | 1.72 | 101 | 1.83 | 0.94 (0.49–1.81) |
Substance use disorder* | 287 | 32.83 | 88 | 1.24 | 26.50 (18.35–38.27) |
Hepatocellular cancera | 30 | – | <=6 | – | – |
Liver failure* | 71 | 4.29 | 38 | 0.65 | 6.63 (3.72–11.81) |
Liver transplanta | 15 | – | 0 | – | – |
Multimorbidity (at least two physical conditions) | 554 | 39.20 | 2053 | 28.48 | 1.38 (1.20–1.58) |
Physical-mental health multimorbidity | 396 | 32.24 | 792 | 11.91 | 2.71 (2.29–3.20) |